SARS-CoV-2 and Variant Diagnostic Testing Approaches in the United States미국에서 SARS-COV-2 및 변형 진단 테스트 접근법Review Published on 2021-12-132022-09-01 Journal: Viruses [Category] SARS, 변종, 진단, 치료기술, [키워드] antibody Antibody Response Antibody responses Antigen approach approval attainment B.1.1.529 Characteristics COVID-19 detect diagnose diagnostic diagnostic testing Diversity Emergency use authorization EUA FDA finding Infection infection with SARS-CoV-2 information Laboratory Multiple nucleic acids omicron PCR performed platform provide reagent reagents recent recent findings review SARS-CoV-2 significantly subsequent Supply chain Support Testing the United State United States variant variants Viral Viral variants [DOI] 10.3390/v13122492 PMC 바로가기 [Article Type] Review
Anti-SARS-CoV-2 S-RBD IgG Antibody Responses after COVID-19 mRNA Vaccine in the Chronic Disorder of Consciousness: A Pilot StudyArticle Published on 2021-12-132022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] acute respiratory syndrome administration age Analysis Anti-spike Antibody Response Antibody responses BNT162b2 both group characterized chronic Chronic disorder Comorbidity controls COVID-19 COVID-19 infection Decline decrease disorder of consciousness domain Efficacy elderly evaluated Follow-up group healthy control healthy controls high risk IgG IgG level indirect chemiluminescence immunoassay individual individuals investigated mRNA mRNA vaccine Multiple regression Patient Pfizer predictor Protein reduction in Research response S-RBD second dose Seroconversion significantly the antibody response vaccination [DOI] 10.3390/jcm10245830 PMC 바로가기 [Article Type] Article
Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia몽골의 4가지 SARS-CoV-2 백신에 대한 항체 반응의 직접 비교Observational Study Published on 2021-12-082022-09-11 Journal: Cell Host & Microbe [Category] MERS, SARS, 변종, 유전자 메커니즘, 임상, 진단, [키워드] Alpha Alpha variant antibody Antibody Response Antibody responses Antibody testing Antibody titer Antibody titers approved AstraZeneca blocking activity caused collected comparison COVID-19 Direct individual Infection Mongolia Mongolian nine participant Pfizer Pfizer/BioNTech plasma Protein Public health intervention Public health interventions RBD RBD-ACE2 Receptor binding domain reported SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine SARS-CoV-2 viral serology Sinopharm specimen Sputnik V stimulate stimulated the antibody response These data vaccination Vaccine vaccine responses Vaccines variant Viral Viral variants [DOI] 10.1016/j.chom.2021.11.004 PMC 바로가기 [Article Type] Observational Study
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment활성 치료 중인 암 환자에서 SARS-CoV-2 mRNA BNT162b2 백신에 대한 불량한 혈청 전환 및 유해 사례의 예측인자Observational Study Published on 2021-12-012022-09-11 Journal: European journal of cancer (Oxford, England : 1990 [Category] MERS, SARS, 바이오마커, 임상, 진단, [키워드] 95% CI Active surveillance active treatment adverse effects adverse event adverse events Antibody Response Antibody responses Antibody responses to the BNT162b2 vaccine benefit BNT162b2 BNT162b2 vaccine Cancer Cancer biological treatment cancer chemotherapy Cancer hormone therapy Cancer immunotherapy cancer patient Cancer patients Cancer target therapy candidate Chemotherapy ClinicalTrials conducted controls COVID-19 vaccine COVID-19 vaccine in cancer patients dose enrolled Factor female greater Hormone therapy IgG IgG response immunisation immunogenicity increasing age lack lymphocyte Lymphocyte count medications Mild mRNA BNT162b2 vaccine non-responders occur of BNT162b2 Older age Patient patients Patients with cancer predict predicted primary endpoint Prospective Study recruited responders risk S1/S2 SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccine adverse effects. second dose Seroconversion Serological testing significantly subject targeted therapy Therapies therapy Treatment women younger patient younger patients younger subject younger subjects [DOI] 10.1016/j.ejca.2021.09.030 PMC 바로가기 [Article Type] Observational Study
Rapid antibody testing for SARS-CoV-2 vaccine response in pediatric healthcare workers소아 의료 종사자의 SARS-CoV-2 백신 반응에 대한 신속한 항체 테스트Article Published on 2021-12-012022-09-11 Journal: International Journal of Infectious Diseases [Category] 진단, 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-Nucleocapsid IgG Anti-spike anti-spike protein IgG antibodies antibody Antibody detection Antibody Response Antibody responses Antibody testing BNT162b2 cassette coronavirus COVID-19 demonstrated dose ELISA ELISA testing evaluate HCW HCWs healthcare healthcare worker humoral Humoral response IgG IgG antibodies IgG antibody IgM antibody IgM/IgG immune response mRNA mRNA vaccination mRNA-1273 neutralization Neutralizing of BNT162b2 participant pediatric Pediatric healthcare workers positive Protein Rapid Rapid test respiratory response to vaccination SARS-CoV-2 SARS-CoV-2 IgM SARS-CoV-2 spike protein SARS-CoV-2 vaccine second dose severe acute respiratory syndrome Coronavirus Spike protein Study participants Test tested the SARS-CoV-2 vaccination [DOI] 10.1016/j.ijid.2021.09.065 PMC 바로가기 [Article Type] Article
Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine비활성화된 SARS-CoV-2 백신에 대한 인간 IgM 및 IgG 반응Article Published on 2021-12-012022-09-11 Journal: Current medical science [Category] MERS, SARS, 진단, 치료기술, [키워드] accelerated age All participant All participants all subjects anti-IgG antibody Antibody Response Antibody responses COVID-19 COVID-19 pandemic defined dose dose of vaccination Effects effort elicited Factor female for inclusion had no healthy individuals Human IgG antibodies IgG antibody IgM IgM and IgG IgM and IgG antibody responses in healthy individual inactivated inactivated SARS-CoV-2 vaccine. individual less male no effect Older positive result recipients response Retrospective study SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine second dose seropositive significantly higher significantly lower subject vaccination vaccine candidates were assessed [DOI] 10.1007/s11596-021-2461-8 PMC 바로가기 [Article Type] Article
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination기도 항체는 COVID-19 중증도에 따라 나타나고 빠르게 감소하지만 SARS-CoV-2 백신 접종 후 다시 나타남Research Article Published on 2021-11-222022-09-12 Journal: JCI Insight [Category] MERS, SARS, 진단, [키워드] acute disease Adaptive immunity addition airway airways antibodies antibody Antibody Response Antibody responses asymptomatic infection boost clinically Cohort convalescence correlated COVID-19 COVID-19 disease COVID-19 disease severity COVID-19 patients COVID-19 severity declined disease elevated evaluated fatal disease highlighting IgA IgG IgG level immune response immune responses immunoglobulins immunology increase in individual individuals infected individual infected individuals Innate immunity mucosal naïve individuals neutralize Prevent prime prime and boost representing required SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination significantly subset the antibody response understanding vaccination Vaccinations viral spread virus [DOI] 10.1172/jci.insight.151463 PMC 바로가기 [Article Type] Research Article
Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases중증, 중등도 및 경증 COVID-19 사례의 회복기 샘플에서 SARS-CoV-2 감염의 혈청학적 바이오마커 분석Comparative Study Published on 2021-11-192022-09-11 Journal: Frontiers in Immunology [Category] MERS, SARS, 바이오마커, 변종, 진단, 치료기술, 치료법, [키워드] acute respiratory syndrome addition antibodies antibody Antibody binding antibody levels Antibody Response Antibody responses Antibody Units Antigen Asymptomatic asymptomatic infection average BAU binding antibodies binding antibody binding antibody units Biomarker Biomarkers candidate Clinical severity convalescent sera correlated correlates of protection COVID-19 COVID-19 disease COVID-19 immune response COVID-19 pandemic COVID-19 patients Electroporation ELISA epidemiological studies Epidemiological study flow cytometry HCW healthcare worker Humoral immunity identify IgA IgM increasingly International international standard international units Lateral flow test microneutralisation test Mild mild or asymptomatic infections multiplex neutralisation neutralisation assay Neutralising Antibodies neutralising antibody neutralising antibody response Neutralising antibody responses nucleocapsid positive correlation Prevalence protection pseudotyped RBD Re-infection respiratory Sample SARS-CoV-2 SARS-CoV-2 antigen SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 spike SARS-CoV-2-specific IgG Serological biomarkers SEROLOGICAL STUDY seronegative seropositive Severe acute respiratory syndrome Severe acute respiratory syndrome-related coronavirus Severe acute respiratory syndrome-related coronavirus-2 severe COVID-19 patient severe COVID-19 patients severity significantly higher spike statistically to define unit vaccination Vaccine vaccine trial variants of concern Virus neutralisation virus neutralisation assay virus neutralising antibody VoC were expressed WHO WHO guideline WHO International Standard World Health Organisation [DOI] 10.3389/fimmu.2021.748291 PMC 바로가기 [Article Type] Comparative Study
Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 20212021 년 방글라데시에서 SARS-COV-2 델타 변형의 분자 및 혈청 학적 특성Article Published on 2021-11-192022-09-01 Journal: Viruses [Category] MERS, SARS, 변종, 진단, 치료법, [키워드] Alpha amino acid mutations anti-N-protein IgG anti-S anti-S-protein IgG antibody Antibody Response Antibody responses association B.1.525 Bangladesh Beta Beta variant beta variants characterization Cohort COVID-19 infection COVID-19 infections COVID-19 pandemic COVID-19 vaccination Delta delta variant Delta variants ELISA evade genome sequence identify IgA IgG Infection Lineage melting curve analysis Mutation mutations natural infection novel nucleotide other variant other variants Patient position positive sample Prospective protective immunity Q677H responses RT-PCR S-protein SARS CoV SARS CoV-2 SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants screened Sequencing single nucleotide Single nucleotide polymorphism Spike protein statistical significance subjects Substitution the SARS-CoV-2 Trigger variant variants Viral Viral load VirSNiP were measured Wuhan-Hu-1 [DOI] 10.3390/v13112310 PMC 바로가기 [Article Type] Article
Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection감염 후 13 개월 동안 SARS-COV-2- 특이 적 항체의 지속성Article Published on 2021-11-192022-09-01 Journal: Viruses [Category] MERS, SARS, 진단, 치료기술, [키워드] antibody Antibody Response Antibody responses Asymptomatic COVID-19 vaccines declined Dynamics exposure to First wave IgG IgG and IgM IgG ELISA IgG level IgG levels IgG/IgM dynamics IgM individual infected individual Infection investigated Lithuania longitudinal study majority Month outbreak pandemic Reinfection remained S protein SARS-CoV-2 SARS-CoV-2 RT-PCR SARS-CoV-2 S SARS-CoV-2 S protein SARS-CoV-2-specific antibodies SARS-CoV-2-specific antibody second wave serological monitoring serological test Serological testing seropositive individual seropositive individuals Seropositivity Severity of infection specific antibodies specific IgM virus-specific antibodies Virus-specific IgG worker [DOI] 10.3390/v13112313 PMC 바로가기 [Article Type] Article